Skip to main content
Top
Published in: International Urology and Nephrology 6/2013

01-12-2013 | Nephrology - Case Report

Renal sarcoidosis with normal serum vitamin D and refractory hypercalcemia

Authors: Abdulkadir Unsal, Taner Basturk, Yener Koc, Tamer Sakacı, Elbis Ahbap, Aysim Ozagarı, Ayşe Sinangil Arar, Cüneyt Akgül, Mustafa Sevınc

Published in: International Urology and Nephrology | Issue 6/2013

Login to get access

Abstract

Introduction

Sarcoidosis is a multi-system disorder characterized by non-caseating epithelioid granulomas in multiple organs. Renal involvement may usually occur as granulomatous interstitial nephritis, but renal failure is uncommon. We report a case of renal-limited sarcoidosis diagnosed by renal biopsy, associated with abnormal calcium metabolism.

Case presentation

A 30-year-old Caucasian male presented with unexplained renal function impairment and hypercalcemia. The patient did not have any history of kidney disease, cough, skin rash, dysuria, hematuria or any other symptoms. Physical examination was unremarkable. Serum creatinine was 2.2 mg/dl and serum calcium was 11.5 mg/dl. Serum intact parathyroid hormone level (12 pg/mL) was decreased. Serum angiotensin-converting enzyme (ACE), 1,25-dihydroxyvitamin D (1,alpha-25 vit D) and pre-proparathyroid hormone (PTHrP) levels and urinary calcium excretion were all in normal range. The renal biopsy showed severe interstitial nephritis with non-caseating granuloma. The patient was treated with prednisone with starting dose of 1 mg/kg. After 2 months of prednisone therapy, serum creatinine decreased. However, because of continued of hypercalcemia unresponsive to low calcium diet and prednisone, chloroquine was prescribed. Six months after the onset, the patient's serum creatinine is stable at 1.30 mg/dl, serum calcium is 10.8 mg/dl, and serum ACE and 1,alpha-25 vit D levels are in normal range. He does not have any signs of extra-renal relapse.

Conclusion

The mechanisms of abnormal calcium metabolism in this patient with renal-limited sarcoidosis are unclear.
Literature
1.
go back to reference Heptinstall R (1992) Interstitial nephritis. In: Heptinstall R (ed) Pathology of the kidney. Little, Brown and Company, New York, pp 1315–1368 Heptinstall R (1992) Interstitial nephritis. In: Heptinstall R (ed) Pathology of the kidney. Little, Brown and Company, New York, pp 1315–1368
2.
go back to reference Baughman RP, Teirstein AS, Judson MA et al (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885–1889PubMedCrossRef Baughman RP, Teirstein AS, Judson MA et al (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885–1889PubMedCrossRef
3.
go back to reference Robson MG, Banerjee D, Hopster D, Cairns HS (2003) Seven cases of granulomatous interstitial nephritis in the absence of extrarenal sarcoid. Nephrol Dial Transplant 18(2):280–284PubMedCrossRef Robson MG, Banerjee D, Hopster D, Cairns HS (2003) Seven cases of granulomatous interstitial nephritis in the absence of extrarenal sarcoid. Nephrol Dial Transplant 18(2):280–284PubMedCrossRef
4.
5.
go back to reference Taylor RL, Lynch HJ, Wysor WG (1963) Seasonal influence of sunlight on the hypercalcemia of sarcoidosis. Am J Med 34(2):221–227PubMedCrossRef Taylor RL, Lynch HJ, Wysor WG (1963) Seasonal influence of sunlight on the hypercalcemia of sarcoidosis. Am J Med 34(2):221–227PubMedCrossRef
6.
go back to reference Hannedouche T, Grateau G, Noel LH et al (1990) Renal granulomatous sarcoidosis: report of six cases. Nephrol Dial Transplant 5:18–24PubMedCrossRef Hannedouche T, Grateau G, Noel LH et al (1990) Renal granulomatous sarcoidosis: report of six cases. Nephrol Dial Transplant 5:18–24PubMedCrossRef
7.
go back to reference Duvic C, Herody M, Rossignol P et al (1999) Renal manifestations of sarcoidosis. A report of nine cases. Rev Med Internet 20:226–233CrossRef Duvic C, Herody M, Rossignol P et al (1999) Renal manifestations of sarcoidosis. A report of nine cases. Rev Med Internet 20:226–233CrossRef
8.
go back to reference Guenel J, Chevet D (1988) Interstitial nephropathies in sarcoidosis. Effect of corticosteroid therapy and long-term evolution. Retrospective study of 22 cases. Nephrologie 9:253–257PubMed Guenel J, Chevet D (1988) Interstitial nephropathies in sarcoidosis. Effect of corticosteroid therapy and long-term evolution. Retrospective study of 22 cases. Nephrologie 9:253–257PubMed
9.
go back to reference Sharma OP, Trowell J, Cohen N et al. (1967) Abnormal calcium metabolism in sarcoidosis. La sarcoidose: Rapport, IV Conférence Internationale. Springfield, Paris, pp 627–32 Sharma OP, Trowell J, Cohen N et al. (1967) Abnormal calcium metabolism in sarcoidosis. La sarcoidose: Rapport, IV Conférence Internationale. Springfield, Paris, pp 627–32
10.
go back to reference Adams JS, Gacad MA (1985) Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 161(4):755–765PubMedCrossRef Adams JS, Gacad MA (1985) Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 161(4):755–765PubMedCrossRef
11.
go back to reference Pinkston P, Saltini C, Muller-Quernheim J, Crystal RG (1987) Corticosteroid therapy suppresses spontaneous interleukin 2 release and spontaneous proliferation of lung T lymphocytes of patients with active pulmonary sarcoidosis. J Immunol 139(3):755–760PubMed Pinkston P, Saltini C, Muller-Quernheim J, Crystal RG (1987) Corticosteroid therapy suppresses spontaneous interleukin 2 release and spontaneous proliferation of lung T lymphocytes of patients with active pulmonary sarcoidosis. J Immunol 139(3):755–760PubMed
12.
go back to reference Adams JS, Diz MM, Sharma OP (1989) Effective reduction in the serum 1,25 dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med 111:437–438PubMedCrossRef Adams JS, Diz MM, Sharma OP (1989) Effective reduction in the serum 1,25 dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med 111:437–438PubMedCrossRef
13.
go back to reference Ackermann D (2007) Hypercalcemia in sarcoidosis–case report, prevalence, pathophysiology and therapeutic options. Ther Umsch 64(5):281–286PubMedCrossRef Ackermann D (2007) Hypercalcemia in sarcoidosis–case report, prevalence, pathophysiology and therapeutic options. Ther Umsch 64(5):281–286PubMedCrossRef
Metadata
Title
Renal sarcoidosis with normal serum vitamin D and refractory hypercalcemia
Authors
Abdulkadir Unsal
Taner Basturk
Yener Koc
Tamer Sakacı
Elbis Ahbap
Aysim Ozagarı
Ayşe Sinangil Arar
Cüneyt Akgül
Mustafa Sevınc
Publication date
01-12-2013
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 6/2013
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-012-0245-6

Other articles of this Issue 6/2013

International Urology and Nephrology 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.